{
"id":"mk19_a_gi_f30",
"number":30,
"bookId":"gi",
"legend":{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Phases of chronic hepatitis B virus infection. It is assumed that patients progress through the phases in sequence, although not all patients develop HBeAg-negative chronic hepatitis B, and only patients with vertical transmission of hepatitis B have a clinically recognized immune tolerant phase. All phases feature positivity for HBsAg, negativity for anti-HBs, and positivity for IgG anti-HBc."
]
},
"footnotes":[
[
"ALT = alanine aminotransferase; anti-HBc = antibody to hepatitis B core antigen; anti-HBe = antibody to hepatitis B e antigen; anti-HBs = antibody to hepatitis B surface antigen; HBeAg = hepatitis B e antigen; HBsAg = hepatitis B surface antigen; HBV = hepatitis B virus; HBV DNA = hepatitis B virus DNA."
],
[
"Data obtained from Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1570. PMID: 29405329 doi:10.1002/hep.29800."
]
],
"imageInfo":{
"hash":"65d60db72db15e7c4a46a3120341a760",
"height":250,
"width":362,
"extension":"svg",
"vector":true
}
}